ATIIFinancial Services · Shell Companies

ATII Stock Forecast: Archimedes Tech SPAC Partners II Co. Price Predictions for 2026-2027

Last close, 15 Oct 2026

$8.50

−15.51% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 32 of 100 as at 15 Oct 2026 — in the lower half.

Market cap

$297.7M

Ticker Nerd rank

32 / 100

Median analyst target

—

Analysts covering

—

Revenue$0.0

Operating income−$101.0M

Net income−$136.8M

Free cash flow−$663K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−20.6%

−20.3%

YTD

−18.0%

From 52W high

−25.3%

From 52W low

0.0%

$11

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

ATII stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Archimedes Tech SPAC Partners II Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Oct 2026

32 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility

Momentum

Size

Value

Issuance

Accruals

Quality

Revisions

Growth

Volatility (88): The share price has been relatively steady.

Growth (18): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ATII stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ATII, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ATII appears on the weeks it earns a place.

Performance

ATII vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 15 Oct 2026, Archimedes Tech SPAC Partners II Co. returned −18.0% against +17.3% for the S&P 500, dividends included.

ATII vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ATII analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Archimedes Tech SPAC Partners II Co. (ATII) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 35.5×
Price / sales: —
Price / book: 3.0×
EV / EBITDA: −378.2×

Growth & margins

Revenue growth (YoY): —
Earnings growth (YoY): 47.1%
Gross margin: —
Operating margin: 0.0%
Net margin: 0.0%

Returns & dividend

Return on equity: 3.4%
Return on assets: 3.3%
Dividend yield: 0.0%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Archimedes Tech SPAC Partners II Co. (ATII) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Archimedes Tech SPAC Partners II Co. has a market value of $297.7M and an enterprise value of $297.3M.
Revenue in the twelve months to 30 June 2026: $0.0.
Net income over the same four quarters: −$130.6M.
Free cash flow in the twelve months to 30 June 2026: −$1.3M.
Shares outstanding: 29.6M.
Trailing P/E: 35.5×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Archimedes Tech SPAC Partners II Co. employs 0 people.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Oct 2026

Data provided by Twelve Data

Peers

ATII vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelShell Companies

Company	Market cap	TKN rank
ATIIArchimedes Tech SPAC Partners II Co.	$297.7M	32
OACCOaktree Acquisition Corp. III Life Sciences	$261.8M	52
NTWONewbury Street II Acquisition Corp.	$260.9M	50
TRGSTRG Latin America Acquisitions Corp.	$263.7M	10
DMAADrugs Made In America Acquisition Corp.	$263.9M	73
CATLCatalyst Acquisition Corp.	$265.4M	5
VNMEVendome Acquisition Corp. I	$257.8M	49

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Archimedes Tech SPAC Partners II Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ATII news & analysis

Archimedes Tech SPAC Partners II Co. Announces Effectiveness of Registration Statement and Date for Extraordinary General Meeting to Approve Proposed Business Combination with Forge Nano, Inc.

GlobeNewsWire · 24 Sept 2026positive

Archimedes Tech SPAC Partners II Co. announced that its registration statement on Form S-4 for its proposed business combination with Forge Nano, Inc. was declared effective by the SEC on September 22, 2026. The company also set an extraordinary general meeting for October 16, 2026, with shareholders of record as of September 1, 2026 eligible to vote.

Why it matters — This marks a key procedural milestone toward shareholder approval of the business combination with Forge Nano, bringing ATII closer to closing the proposed transaction.

Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines

GlobeNewsWire · 22 Sept 2026positive

Forge Nano, Inc., which has agreed to merge with Archimedes Tech SPAC Partners II Co. (ATII), announced a Joint Development Agreement with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of programs.

Why it matters — For ATII watchers, this expands Forge Nano's business beyond its core semiconductor and defense applications into pharmaceutical manufacturing, signaling potential new growth avenues for the post-merger company.

Forge Nano Expands Partnership with Battery AI Software Leader Voltaiq to Put AI at the Center of Battery Development and Manufacturing

GlobeNewsWire · 17 Sept 2026positive

Forge Nano, which has agreed to merge with Archimedes Tech SPAC Partners II Co. (ATII), announced an expansion of its partnership with battery AI platform Voltaiq. Forge Nano plans to integrate AI across its battery operations via Voltaiq's data infrastructure and AI-powered analytics, covering R&D, product development, manufacturing and quality.

Why it matters — ATII watchers would care because this expanded partnership signals Forge Nano's progress in scaling toward high-volume U.S.-based battery manufacturing with AI integration, reflecting the company's operational advancement ahead of the planned merger.

Forge Nano to Host Pre-Listing Investor & Analyst Update Webcast on September 22, 2026

GlobeNewsWire · 15 Sept 2026positive

Forge Nano, which has agreed to merge with Archimedes Tech SPAC Partners II Co., announced it will host a pre-listing investor and analyst update webcast on September 22, 2026, covering strategic, commercial, capital and manufacturing milestones ahead of the anticipated NASDAQ listing. The event will include prepared remarks followed by a moderated Q&A session.

Why it matters — For ATII watchers, this webcast signals forward progress and provides a scheduled opportunity for management to update investors on key milestones as the anticipated NASDAQ listing draws closer.

Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC

GlobeNewsWire · 2 Sept 2026neutral

Archimedes Tech SPAC Partners II Co. announced that on September 2, 2026, it filed a third amendment to its Form S-4 registration statement with the SEC in connection with its previously announced proposed business combination with Forge Nano, Inc. The registration statement, filed by ATII's wholly-owned subsidiary Pubco and Forge Nano, includes a preliminary proxy statement/prospectus and has not yet been declared effective.

Why it matters — The filing marks continued progress in the regulatory review process toward completing the proposed Forge Nano business combination, which ATII shareholders and watchers are tracking.

FAQ

Frequently asked questions about ATII stock

How does Ticker Nerd's model rank ATII?

As at 15 Oct 2026, Archimedes Tech SPAC Partners II Co. ranks 32 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (88 of 100).

What is the ATII stock forecast for 2030?

No analyst covering Archimedes Tech SPAC Partners II Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ATII are extrapolating price history, which says nothing about the business.

How has ATII stock performed over the past year?

Archimedes Tech SPAC Partners II Co. returned -18.0% over the 12 months to 15 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Archimedes Tech SPAC Partners II Co. do?

Archimedes Tech SPAC Partners II Co. is a special purpose acquisition company that focuses on identifying and completing a business combination with a company in the technology sector.

What is the latest news on ATII?

The most recent item we track (GlobeNewsWire, 24 Sept 2026): "Archimedes Tech SPAC Partners II Co. Announces Effectiveness of Registration Statement and Date for Extraordinary General Meeting to Approve Proposed Business Combination with Forge Nano, Inc.". Archimedes Tech SPAC Partners II Co. announced that its registration statement on Form S-4 for its proposed business combination with Forge Nano, Inc. was declared effective by the SEC on September 22, 2026. The company also set an extraordinary general meeting for October 16, 2026, with shareholders of record as of September 1, 2026 eligible to vote.

Company

About Archimedes Tech SPAC Partners II Co.

Archimedes Tech SPAC Partners II Co. is a special purpose acquisition company that focuses on identifying and completing a business combination with a company in the technology sector. Its mandate centers on industries such as artificial intelligence, cloud services, and automotive technology, using the SPAC structure to bring private businesses into the public markets. The company currently operates as a blank check vehicle and does not conduct traditional operating business activities. It issues units, ordinary shares, and warrants as part of its capital structure, reflecting the standard SPAC model used in public market transactions. Based in Claymont, Delaware, Archimedes Tech SPAC Partners II Co. plays a market role as an acquisition platform for technology-oriented businesses seeking public listing through merger or similar transaction.

CEO Mr. Long Long · United States · https://www.archimedesspac2.com